Skip to main content Deutsch

Detail

Andreas Kerschbaumer
Dr. med. univ. Andreas Kerschbaumer

Department of Medicine III (Division of Rheumatology)

ORCID: 0000-0002-6685-8873

Keywords

Arthritis, Psoriatic; Arthritis, Rheumatoid

Research interests

Dr. Kerschbaumer performed his PhD studies under the supervision of Professors Smolen and Aletaha, focusing on outcomes and epidemiological research in rheumatoid and psoriatic arthritis, and has a strong interest in big data analysis and novel metanalytical methods. In his thesis he focussed on discovering influencing factors on efficacy results in clinical trials in RA and PsA. He had key roles in several international taskforces, including the 2019 and 2022 EULAR management recommendations for pharmacologic treatment of RA, as well as those for PsA in 2019 and 2023, and he was engaged as a co-methodologist of the EULAR taskforce ‘Points to consider for conducting trials in patients who are at risk for developing arthritis’. 

Selected publications

  1. Kerschbaumer, A. et al. (2020) ‘Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology’, Nature Medicine, 26(6), pp. 974–980. Available at: http://dx.doi.org/10.1038/s41591-020-0833-4.
  2. Kerschbaumer, A. et al. (2022) ‘Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis’, Annals of the Rheumatic Diseases, 81(10), pp. 1374–1378. Available at: http://dx.doi.org/10.1136/annrheumdis-2021-221807.
  3. Kerschbaumer, A. et al. (2023) ‘Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis’, Annals of the Rheumatic Diseases, p. ard-2022-223349. Available at: http://dx.doi.org/10.1136/ard-2022-223349.
  4. Kerschbaumer, A. et al. (2022) ‘Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis’, Annals of the Rheumatic Diseases, 82(1), pp. 95–106. Available at: http://dx.doi.org/10.1136/ard-2022-223365.
  5. Kerschbaumer, A. et al. (2017) ‘The effects of structural damage on functional disability in psoriatic arthritis’, Annals of the Rheumatic Diseases, 76(12), pp. 2038–2045. Available at: http://dx.doi.org/10.1136/annrheumdis-2017-211433.